Skip to main content
. 2018 Aug 14;9(63):32204–32218. doi: 10.18632/oncotarget.25941

Table 2. FISH positive cases, corresponding molecular subtypes, RNA ISH and clinical data.

No. FISH RNA ISH
Receptor/ligand Tumor type RAS PIK3CA BRAF Ratio Average FGF(R) signals (%) Cells with ≥5 FGF(R) signals (%) Ampli-fication level H-score Result
1 FGFR1 C WT -- -- 1.8 5.7 60 Low 100 neg (FGFR1)
2*(36) FGFR1 R WT -- -- 1.2 5.5 66.7 Low 101
310
neg (FGFR1)
pos (FGFR3)
3 FGFR1 R WT -- -- 3.0 4.7 56.7 High 101 neg (FGFR1)
4 FGFR1 R Mt -- -- 4.4 11.4 95 High 180 neg (FGFR1)
5 FGFR1 R WT -- -- 2.1 3.2 33.3 High 101 neg (FGFR1)
6 FGFR1 LM/C WT WT WT 2.0 3.6 35.0 High 105 neg (FGFR1)
7*(35) FGFR1 LM/R WT WT WT 2.4 4.9 48.3 High 135
360
neg (FGFR1)
pos (FGFR3)
8*(37) FGF3,4,19 R WT -- -- 2.9 5.1 45.0 High 310 pos (FGFR3)
9*(28) FGF3,4,19 C WT -- -- 12.9 29.9 100 High 250 pos (FGFR1)

*(X), number of the same case in Table 1 ; M, male; F, female; tumor types: C, primary colonic cancer; R, primary rectal cancer; LM/C, liver metastasis with primary tumor in the colon; LM/R, liver metastasis with primary tumor in the rectum; Mt, mutation; WT, wildtype; neg, negative; pos, positive; --, data not available.